PerformanceMedium Risk
Hexarelin
Also known as: Examorelin, EP-23905
- Half-life:
- ~30-60 minutes
Administration Routes
subcutaneous injection
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Mechanism of Action
Potent synthetic GHRP; strongest GH secretagogue in its class; also activates CD36 scavenger receptor for cardioprotective effects
The most potent synthetic GHRP, stimulating significant GH release. Also has direct cardioprotective properties independent of GH.
Primary Research Areas
- potent GH release
- cardiac protection
- muscle growth
Risk Profile
Medium Risk
Moderate risk profile in research contexts. Consult a healthcare professional before use.
Regulatory Status
Research OnlyNot Evaluated by FDA
Potent hexapeptide GH secretagogue. No FDA approval anywhere. Not on FDA Category 1 or Category 2 list. WADA prohibited. More potent GH pulse than GHRP-6. Research use only.
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.